Resonance Health (ASX:RHT) Share Price and News

Market Cap (18-Apr) $18,384,640 (1,108th)	Close (30-Jun) $0.042 0 (0%)	Volume (30-Jun) 149,220	Shortsold (10-Feb) 15,546 (0.00%) (581st)
52w High $0.085	52w Low $0.035	P/E -	EPS 0

	Subject
	RHT RHT Ann: Receipt of R&D Tax Incentive Refund
	1 (current) 2 3
	RHT RHT Ann: Updated HepaFatSmart Cleared by US FDA
	RHT RHT Ann: Management Transition
	RHT RHT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RHT RHT Ann: Director Appointment & Appendix 3X
	RHT RHT Ann: Change of Director's Interest Notice
	RHT RHT Ann: Half Yearly Report and Accounts
	RHT RHT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RHT RHT Ann: Change of Director's Interest Notice
	RHT RHT Ann: MRI Fibrosis Provisional Patent Application Lodged
	RHT RHT Ann: Notification of cessation of securities - RHT
	RHT RHT Ann: Notification of cessation of securities - RHT
	RHT RHT Ann: Notification of cessation of securities - RHT
	RHT RHT Ann: Results of Meeting
	RHT RHT Ann: Investor Presentation
	RHT RHT Ann: Resonance Health Contracted for Two New Clinical Trials
	RHT RHT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RHT RHT Ann: Resonance Health Launches Resonance Clinical
	RHT RHT Ann: Notice of Annual General Meeting/Proxy Form
	RHT RHT Ann: 2022 AGM Notification of Dates
	RHT RHT Ann: Appendix 4G and Corporate Governance Statement
	RHT RHT Ann: Annual Report to shareholders
	RHT RHT Ann: Preliminary Final Report
	RHT RHT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RHT RHT Ann: FerriScan Now Available on 3 Tesla (3T) MRI Machines
	RHT RHT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RHT RHT Ann: Company Secretary Appointment/Resignation
	RHT RHT Ann: Investor Presentation April 2022
	RHT RHT Ann: Platform Integration & Partnership Agreement with CARPL.ai
	RHT RHT Ann: Half Yearly Report and Accounts
	RHT RHT Ann: US CPT Code Confirmation for LiverSmart
	RHT RHT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RHT RHT Ann: Resonance Health Enters China - Pharma Contract Signed
	RHT RHT Ann: Resonance Health Contracted for Third Party Clinical Trial
	RHT RHT Ann: Change in substantial holding
	RHT RHT Ann: US FDA Clearance for LiverSmart
	RHT RHT Ann: ASO Project New Data
	RHT RHT Ann: LiverSmart Submitted to FDA for US Regulatory Clearance
	RHT RHT Ann: Jobkeeper Announcement
	RHT RHT Ann: Results of Meeting
	RHT RHT Ann: Investor Presentation - Positioning for Growth
	RHT RHT Ann: Appointment of CMO - Professor John Olynyk
	RHT RHT Ann: ASO R&D Project - Filing of Two Patent Applications
	RHT RHT Ann: Thalassaemia International Federation to Deploy FerriSmart
	RHT RHT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RHT RHT Ann: Notice of Annual General Meeting/Proxy Form
	RHT RHT Ann: Sales & Marketing Update
	RHT RHT Ann: New AI Medical Device
	RHT RHT Ann: AGM Date and Director Nomination Closing Date
	RHT RHT Ann: Appendix 4G and Corporate Governance Statement

Similar Companies

Atomo Diagnostics

AT1

Cochlear

COH

CleanSpace Holdings

CSX

Cyclopharm

CYC

EMvision Medical Devices

EMV

Imagion Biosystems

IBX

ImpediMed

IPD

Micro-X

MX1

Respiri

RSH

SomnoMed

SOM

End of Day Prices

Date	Close	Volume	Change
17-Apr	$0.04	42,191	0.00 (7.50%)
16-Apr	$0.04	0	0.00 (2.44%)
14-Apr	$0.04	45,000	+0.00 (7.89%)
11-Apr	$0.04	0	0.00 (5.00%)
08-Apr	$0.04	469,765	+0.00 (14.29%)
07-Apr	$0.04	867,686	0.00 (5.41%)
04-Apr	$0.04	74,746	0.00 (0.00%)
03-Apr	$0.04	140,000	0.00 (0.00%)
02-Apr	$0.04	106,607	0.00 (2.63%)
31-Mar	$0.04	4,610	0.00 (0.00%)
28-Mar	$0.04	475,853	0.00 (0.00%)
27-Mar	$0.04	832,952	0.00 (7.32%)
26-Mar	$0.04	130,000	+0.00 (2.50%)
24-Mar	$0.04	0	0.00 (0.00%)
21-Mar	$0.04	577,137	0.00 (9.09%)
3 up, 7 down, and 5 flat days

High $0.04	Low $0.04	Trades 9	Turnover $6,168	Volume 149,220
30 June 2023 at 4:10pm

High $0.04	Low $0.04	Trades 9	Turnover $6,168	Volume 149,220
30 June 2023 at 4:10pm

Resonance Health Health Care

$0.042 0.001 (2.44%)

$0.042 0.001 (2.44%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices